Figure 1. Conventional CVD risk factors at baseline, their HRs and discriminative ability for fatal or non-fatal hospitalised CVD. Values are given as median and IQR, or number of cases (%). Baseline data of 714 patients are included. All models are stratified by recruitment site. There were <5% missing values for descriptive variables such as body mass index and smoking status. Missing values were addressed using multiple imputations using chained equations. aModel includes age and sex. bModel includes conventional CVD risk factors: age, sex, smoking, HDL, total cholesterol, SBP, diabetes and hypertension medication. CVD, cardiovascular disease; HDL, high-density lipoprotein; SBP, systolic blood pressure.
Figure 2. Aortic stiffness at baseline, their HRs and discriminative ability for fatal or non-fatal hospitalised CVD. Values are given as median and IQR, or number of cases (%). Baseline data of 714 patients are included. All models are stratified by recruitment site. Gronnesby and Borgan goodness of fit (χ2(3), p>χ2): CV risk model (2.07, 0.559), aPWV (1.64, 0.652), CIMT (2.32, 0.509), and AIx (3.08, 0.380). Estimates based on quartiles of risk. Brier score: CV risk model 0.129 (95% CI 0.111 to 0.146), aPWV 0.126 (95% CI 0.108 to 0.145), CIMT 0.128 (95% CI 0.110 to 0.147) and AIx 0.126 (95% CI 0.109 to 0.144). Lower score indicates better accuracy of estimates. aModel includes age and sex. bModel includes conventional CVD risk factors: age, sex, smoking, high-density lipoprotein, total cholesterol, SBP, diabetes and hypertension medication. CIMT further included SBP. Carotid–femoral aPWV further included mean arterial pressure and resting heart rate. AIx further included resting heart rate and height. There were about 10% missing values for variables CIMT (n=66) and aPWV (n=60). Missing values were addressed using multiple imputations using chained equations. AIx, Augmentation Index;…
Figure 3. Alternative measures at baseline, their HRs and discriminative ability for fatal or non-fatal hospitalised CVD. Values are given as median and IQR, or number of cases (%). Baseline data of 714 patients are included. All models are stratified by recruitment site. Gronnesby and Borgan goodness of fit (χ2(3), p>χ2): CV risk model (2.07, 0.559); CRP (0.32, 0.956); fibrinogen (1.48, 0.687); glucose (0.42, 0.936); BMI (1.56, 0.668); GOLD (5.63, 0.131); 4MGS (4.70, 0.195); 6MWT (2.94, 0.401); BODE (6.46, 0.091); BMI, 4MGS, 6MWT, bode (4.12, 0.249). Estimates based on quartiles of risk. Brier score: CV risk model 0.129 (95% CI 0.111 to 0.146); CRP 0.125 (95% CI 0.107 to 0.142); fibrinogen 0.128 (95% CI 0.111 to 0.146); glucose 0.128 (95% CI 0.111 to 0.146); BMI 0.128 (95% CI 0.111 to 0.146); GOLD 0.128 (95% CI 0.110 to 0.146); 4MGS 0.127 (95% CI 0.110 to 0.144); 6MWT 0.123 (95% CI 0.105 to 0.140); BODE 0.124 (95% CI 0.106 to 0.142); BMI, 4MGS, 6MWT, BODE 0.122 (95% CI 0.104 to 0.140). Lower score indicates better accuracy of estimates. aModel includes age and sex. bModel includes conventional CVD risk factors: age, sex, smoking, high-density lipoprotein, total cholesterol, systolic blood…
We only have this paper's title and publication details.
Answers are grounded in this paper and cite their sources.
Id 11101.
No takes yet. Share an insight, caveat, or question.
Fermont et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: